Approval · Notice of Compliance 30203 · 2023
NORVASC: Notice of Compliance 30203
Issued February 24, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30203
- Date
- February 24, 2023
- Company
- Upjohn Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to labels to align with Plain Language Labelling (PLL) regulations Removal of strength Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVASC | Not yet assigned | — |
Medicinal ingredients
- AMLODIPINE BESYLATE 10 MG per TAB
- AMLODIPINE BESYLATE 5 MG per TAB